Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial Meeting Abstract

  

Authors:	Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; Hyman, D. M.; Rudin, C. M.; Gedvilaite, E.; Tsui, D.; Arcila, M. E.; Kris, M. G.; Weitsman, G.; Ng, T.; Scaltriti, M.; Ho, A. L.
Abstract Title:	Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	342s
Language:	English
ACCESSION:	WOS:000487345805586
DOI:	10.1200/JCO.2019.37.15_suppl.6001
PROVIDER:	wos
Notes:	Meeting Abstract: 6001 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156341